Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

41.34USD
17 Feb 2017
Change (% chg)

$0.42 (+1.03%)
Prev Close
$40.92
Open
$41.02
Day's High
$41.34
Day's Low
$40.88
Volume
4,272,870
Avg. Vol
3,902,155
52-wk High
$45.58
52-wk Low
$37.20

GSK

Chart for GSK

About

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $99,924.17
Shares Outstanding(Mil.): 2,455.20
Dividend: 0.58
Yield (%): 6.44

Financials

  GSK Industry Sector
P/E (TTM): 89.98 28.47 29.39
EPS (TTM): 0.46 -- --
ROI: 2.93 13.57 13.06
ROE: 29.24 14.45 14.19

Gilead challenges GSK with strong HIV drug data

LONDON Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the same way as the British group's successful dolutegravir.

Feb 14 2017

Gilead challenges GSK with strong HIV drug data

LONDON, Feb 14 Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the same way as the British group's successful dolutegravir.

Feb 14 2017

BRIEF-GSK announces positive final stage results for two-drug HIV treatment

* Announces detailed positive phase III results for investigational two-drug regimen of dolutegravir and rilpivirine for HIV treatment

Feb 14 2017

PRESS DIGEST- Financial Times - Feb 14

Feb 14 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Feb 13 2017

GSK asks judge to toss several claims from generic Paxil case

GlaxoSmithKline has urged a federal judge in Illinois to toss several claims to a lawsuit alleging that a generic version of its antidepressant Paxil caused a Reed Smith partner's suicide.

Feb 13 2017

PRESS DIGEST- British Business - Feb 9

Feb 9 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Feb 08 2017

GlaxoSmithKline and Gilead to face off at HIV meeting next week

LONDON GlaxoSmithKline and Gilead Sciences will vie for business in treating HIV patients next week when both companies unveil clinical trial results at a medical meeting in Seattle.

Feb 08 2017

GlaxoSmithKline and Gilead to face off at HIV meeting next week

LONDON, Feb 8 GlaxoSmithKline and Gilead Sciences will vie for business in treating HIV patients next week when both companies unveil clinical trial results at a medical meeting in Seattle.

Feb 08 2017

BRIEF-GSK says launched flonase sensimist allergy relief nationwide

* GSK Consumer Healthcare - announced nationwide launch of flonase sensimist allergy relief Source text for Eikon: Further company coverage:

Feb 08 2017

Weak pound buoys GSK but drugmaker warns on 2017 generic threat

LONDON, Feb 8 GlaxoSmithKline sales and profits jumped in the fourth quarter, helped by falling sterling, but the drugmaker cautioned profit growth could be impacted in 2017 by generic competition to its top-selling lung drug Advair.

Feb 08 2017

More From Around the Web

Competitors

Earnings vs. Estimates